Drug Free Solution, Inc. (DSOL) Stock

About Drug Free Solution, Inc.

Based in El Segundo, California, Drug Free Solution, Inc. operates as a lifestyle enterprise focused on emotional well-being. The company offers its proprietary "Living Breath Process," an innovative, three-stage technique that integrates self-reflection, guided breathing, and specific linguistic patterns. This method is designed to cater to various needs, including addiction prevention and recovery, personal growth, emotional health, and overall lifestyle enhancement. Beyond its core process, Drug Free Solution, Inc. also provides the "Living Breath Series" of programs, which bundles related products, educational resources, and supportive services. A significant arm of the company's mission is the "Living Breath Project." This initiative leverages distinct protocols, lifestyle-enhancing products, and comprehensive training and education to foster the establishment of community wellness centers, dedicated wellness residences, and essential support networks within correctional facilities. The overarching goal of these efforts is to significantly reduce addiction and incarceration rates across the United States. Known as Living Breath Project, Inc. until its renaming in January 2014, the company subsequently adopted its present corporate identity.

Drug Free Solution, Inc. (DSOL) stock trades at $0.00 with a market capitalization of $113361. The stock is valued at a price-to-earnings (P/E) ratio of -16.94, price-to-book of -0.40, price-to-sales of 53.96. Over the past 52 weeks the stock has ranged between $0.00 and $0.10, and currently trades 100.0% below its 52-week high.

On profitability, Drug Free Solution, Inc. generates a return on equity (ROE) of 2.58%, return on capital employed of 2.38%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: www.drugfreesolution.com